Steward Partners Investment Advisory’s PRA Health Sciences, Inc. PRAH Stock Holding History

Steward Partners Investment Advisory’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-400	Closed	-$44K	–	2790
2019 Q4	$44K	Sell	400 -42	-10%	-$4.32K	﹤0.01%	1463
2019 Q3	$43K	Sell	442 -60	-12%	-$5.96K	﹤0.01%	1423
2019 Q2	$49K	Buy	+502	New	+$47.9K	﹤0.01%	1346
2018 Q4	–	Sell	-42	Closed	-$5K	–	2422
2018 Q3	$5K	Sell	42 -400	-90%	-$41.6K	﹤0.01%	2156
2018 Q2	$41K	Hold	442	–	–	﹤0.01%	1185
2018 Q1	$36K	Buy	442 +150	+51%	+$13.3K	﹤0.01%	1119
2017 Q4	$26K	Buy	+292	New	+$24.3K	﹤0.01%	1036

Other funds holding PRAH

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

NIPH

NN Investment Partners Holdings The Hague, Netherlands $18.6B AUM 18.31% 1-Year Est. Return

Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return

Steward Partners Investment Advisory's PRAH Position: Q1 2020 in Review

Steward Partners Investment Advisory sold out of PRA Health Sciences, Inc. (PRAH) in Q1 2020, closing a stake of 400 shares — an estimated $44K sold.

Steward Partners Investment Advisory first reported a position in PRAH in Q4 2017 and held it in 7 quarters. The position peaked at $49K in Q2 2019. 301 funds tracked by Wall St. Rank hold PRAH as of Q1 2020.

Steward Partners Investment Advisory reported no remaining PRA Health Sciences, Inc. position as of Q1 2020 after selling out during the quarter.
Steward Partners Investment Advisory sold 400 PRA Health Sciences, Inc. shares in Q1 2020, an estimated $44K.
Steward Partners Investment Advisory first reported a position in PRA Health Sciences, Inc. in Q4 2017 and held it in 7 quarters.
Steward Partners Investment Advisory's PRA Health Sciences, Inc. position peaked at $49K in Q2 2019.
301 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q1 2020.

Based on Steward Partners Investment Advisory's 13F filing for Q1 2020, filed 29 Apr 2020.